Back
Avadel Pharmaceuticals PLC Vs. Sarepta Therapeutics Industry Stock Comparison
Sell
44
AVDL
Avadel Pharmaceuticals PLC
Last Price:
$8.20
Seasonality Move:
7.32%
Buy
52
SRPT
Sarepta Therapeutics
Last Price:
$73.63
Seasonality Move:
14.66%
Sell
44
Avadel Pharmaceuticals PLC (AVDL)
is a Sell
Is Avadel Pharmaceuticals PLC a Buy, Sell or Hold?
-
The current Avadel Pharmaceuticals PLC [AVDL] share price is $8.53. The Score for AVDL is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
-
AVDL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
52
Sarepta Therapeutics (SRPT)
is a Buy
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $76.33. The Score for SRPT is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
-
SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
AVDL Stock Price Chart
What is Avadel Pharmaceuticals PLC's stock price today?
-
The Avadel Pharmaceuticals PLC share price today is $8.53Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AVDL is experiencing slight selling pressure.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $76.33Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.
AVDL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.06 | Buy |
Relative Strength Index (14 RSI): | 53.64 | Buy |
Chaikin Money Flow: | -101275 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.87 - 8.67) | Buy |
Bollinger Bands (100): | (7.78 - 12.22) | Sell |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -9.07 | Sell |
Relative Strength Index (14 RSI): | 30.8 | Sell |
Chaikin Money Flow: | 1304026 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (86.54 - 110.54) | Sell |
Bollinger Bands (100): | (102.23 - 127.85) | Sell |
AVDL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 8.59 | Sell |
20-day SMA: | 8.18 | Buy |
50-day SMA: | 8.27 | Buy |
200-day SMA: | 12.44 | Sell |
8-day EMA: | 8.51 | Buy |
20-day EMA: | 8.37 | Buy |
50-day EMA: | 8.71 | Sell |
200-day EMA: | 11.36 | Sell |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 84.29 | Sell |
20-day SMA: | 96.26 | Sell |
50-day SMA: | 107.61 | Sell |
200-day SMA: | 124.92 | Sell |
8-day EMA: | 82.75 | Sell |
20-day EMA: | 92.99 | Sell |
50-day EMA: | 104.03 | Sell |
200-day EMA: | 117.97 | Sell |
Avadel Pharmaceuticals PLC Earnings Growth & AVDL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.06 per share, an increase this year of $0.65 per share, and an increase next year of $0.47 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.52 per share, a decrease next quarter of $0.64 per share, an increase this year of $5.33 per share, and an increase next year of $5.23 per share.
Avadel Pharmaceuticals PLC Technical Analysis
Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |